Jamie Gowryluk - Medicure VP Operations

All Insiders . Canada . 
Stock . Medicure . Stakeholders . Insider . Jamie Gowryluk
MPH Stock  CAD 0.99  0.09  10.00%   

Insider

Jamie Gowryluk is VP Operations of Medicure
Address 2-1250 Waverley Street, Winnipeg, MB, Canada, R3T 6C6
Phone204 487 7412
Webhttps://www.medicure.com

Medicure Management Efficiency

The company has return on total asset (ROA) of (0.0563) % which means that it has lost $0.0563 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.129) %, meaning that it generated substantial loss on money invested by shareholders. Medicure's management efficiency ratios could be used to measure how well Medicure manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.06 in 2024. Return On Capital Employed is likely to climb to -0.04 in 2024. At this time, Medicure's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to climb to about 16.1 M in 2024, whereas Other Assets are likely to drop slightly above 62.3 K in 2024.
Medicure has accumulated 544 K in total debt with debt to equity ratio (D/E) of 0.7, which is about average as compared to similar companies. Medicure has a current ratio of 4.62, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Medicure until it has trouble settling it off, either with new capital or with free cash flow. So, Medicure's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Medicure sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Medicure to invest in growth at high rates of return. When we think about Medicure's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 13 records

INSIDER Age

Simon SmithCovalon Technologies
N/A
Michael TremblayKnight Therapeutics
N/A
Chuoru LiCipher Pharmaceuticals
N/A
Jeff MartensKnight Therapeutics
N/A
Nicolas SujoyKnight Therapeutics
N/A
Jason GorelCovalon Technologies
N/A
Ren GoehrumBiosyent
65
Janice MurrayKnight Therapeutics
N/A
Bryan JacobsCipher Pharmaceuticals
N/A
David MillerCipher Pharmaceuticals
N/A
BA BAKnight Therapeutics
53
Daniela MarinoKnight Therapeutics
N/A
Ron HebertCovalon Technologies
N/A
Medicure Inc., a pharmaceutical company, engages in the development and commercialization of therapies for the cardiovascular market in the United States. The company was founded in 1997 and is headquartered in Winnipeg, Canada. MEDICURE INC operates under Biotechnology classification in Canada and is traded on TSX Venture Exchange. Medicure (MPH) is traded on TSX Venture Exchange in Canada and employs 5 people. Medicure is listed under Pharmaceuticals category by Fama And French industry classification.

Management Performance

Return On Equity-0.13
Return On Asset-0.0563

Medicure Leadership Team

Elected by the shareholders, the Medicure's board of directors comprises two types of representatives: Medicure inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medicure. The board's role is to monitor Medicure's management team and ensure that shareholders' interests are well served. Medicure's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medicure's outside directors are responsible for providing unbiased perspectives on the board's policies.
Neil Owens, President COO
CPA BCom, Chief Officer
Albert Friesen, Founder, Chairman and CEO
Jamie Gowryluk, VP Operations
Reuben Saba, Vice Affairs

Medicure Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Medicure a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-0.13
Return On Asset-0.0563
Profit Margin(0.13) %
Operating Margin(0.22) %
Current Valuation6.37 M
Shares Outstanding10.44 M
Shares Owned By Insiders26.67 %
Shares Owned By Institutions23.09 %
Number Of Shares Shorted2.69 K
Price To Earning22.88 X

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Medicure Stock Analysis

When running Medicure's price analysis, check to measure Medicure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicure is operating at the current time. Most of Medicure's value examination focuses on studying past and present price action to predict the probability of Medicure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicure's price. Additionally, you may evaluate how the addition of Medicure to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY